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ABSTRACT 
 
Background: Primary care services frequently provide the initial contact between people with dementia and 
health service providers. Early diagnosis and screening programmes have been suggested as a possible strategy to 
improve the identification of such individuals and treatment and planning health and social care support.  
Objective: To determine what early diagnostic and screening programmes have been adopted in primary care 
practice, to explore who should deliver these and to determine the possible positive and negative effects of an 
early diagnostic and screening programme for people with dementia in primary care.  
Methods: A systematic review of the literature was undertaken using published and unpublished research 
databases. All papers answering our research objectives were included. A narrative analysis of the literature was 
undertaken, with the CASP tools used appropriately to assess study quality.  
Results: Thirty-three papers were identified of moderate to high quality. The limited therapeutic options for those 
diagnosed with dementia means that even if such a programme were instigated, the clinical value remains 
questionable. Furthermore accuracy of the diagnosis remains difficult to assess due to poor evidence and this 
raises questions regarding whether people could be over- or under-diagnosed. Given the negative social and 
psychological consequences of such a diagnosis, this could be devastating for individuals.  
Conclusions: Early diagnostic and screening programme have not been widely adopted into primary care. Until 
there is rigorous evidence assessing the clinical and cost-effectiveness of such programmes, there remains 
insufficient evidence to support the adoption of these programmes in practice.  
 
Keywords: Diagnostic; Population screening; cognitive impairment; experiences; general practice; community 
services 
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INTRODUCTION 
 
Dementia is a growing issue for society. An estimated 47.7 million people globally suffer from Alzheimer’s 
disease (AD), the most common dementia subtype [1]. Alzheimer’s disease pathology begins long before 
cognitive and functional impairments are noticed thus early intervention might delay symptom onset and 
progression. If no breakthrough can be made to prevent the disease or delay its onset, the number of people with 
dementia is anticipated to reach 135 million by 2050 [2].  
By 2030 it is estimated that the global cost of caring for people living with dementia could be US$1.2 trillion or 
more [3]. By 2047, assuming a curvilinear association between age and dementia risk, a 2-year delay in onset 
would reduce population incidence by 22% [3] resulting in 25 million fewer cases worldwide [4,5].  In addition 
to these economic impacts, there is increasing evidence linking modifiable risk factors, such as diabetes mellitus, 
hypertension, obesity, physical inactivity, depression, smoking, and educational attainment with dementia 
incidence [6].   
Currently early diagnosis, information, advance care planning, cognitive stimulation therapy, management of 
neuropsychiatric symptoms, strategies for family carers, cholinesterase inhibitors and memantine in dementia and 
changes in attitudes, including highlighting personhood and living well with dementia, have made notable strides 
forward but there is, as yet, no cure, effective preventative intervention nor disease modifying treatment for the 
common dementias.   
The diagnosis of dementia is advancing in terms of accuracy, but there are still major technical and ethical issues 
for implementation [7]. Primary care is the first access point for many people with memory concerns but there 
may not be the resources or skill-set to manage the complex care needs of this of every increasing number of 
patients.  
A recent systematic review examined the wider attitudes and preferences of the general public, health care 
professionals, people with dementia and their carers towards screening for dementia [8]. In their review, Martin 
et al [8] did not aim to specifically examine what diagnostic practices were, who should deliver ‘early diagnosis 
of dementia programmes’ in primary care and what the potential positive/negative effects of such interventions 
might be. The intention of this systematic review is to  address these specific questions.   
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MATERIALS AND METHODS 
 
A systematic review methodology was undertaken according to established methods of systematic reviewing [9] 
and reported in accordance with the PRISMA reporting statement [10]. 
 
Aim 
The aims of this review were to determine: 
a) What the clinical practices are in early diagnosis and screening approaches for dementia in primary care. 
b) Who should deliver early diagnostic and screening programmes for dementia in primary care? 
c) What are the potential positive and negative effects of early diagnosis or screening programmes for 
dementia in primary care? 
 
Search Strategy 
The primary search strategy was conducted on the electronic databases MEDLINE, AMED, EMBASE, PubMed 
using the search strategy terms and Boolean operators as presented in Table 1. In addition, a secondary search of 
the grey literature and trial registries was conducted including the databases: OpenGrey, WHO International 
Clinical Trials Registry Platform, Current Controlled Trials, UKCRN Portfolio Database, National Technical 
Information Service and the UK National Research Register Archive.  
The search was undertaken from each database’s inception to 5th October 2015. A review of the potentially 
included papers’ reference lists and previous review articles was undertaken to identify any additional studies not 
identified by the primary search. 
Eligibility criteria 
All papers presenting data on the screening or diagnosis of people for dementia, conducted in primary 
(community) care or family practice, were eligible for inclusion in this review. Since we were particularly 
interested in the diagnosis of older people with dementia, we excluded studies where 80% or more of their cohort 
consisted of people aged less than 65 years. We included papers reporting all types of dementia, regardless of the 
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form of primary care screening/diagnostic services, age, quality or language of publication. All study designs were 
considered for inclusion.  
Selection of Studies and Data Extraction 
Two review authors (TS and FC) independently reviewed the titles and abstracts from all search results based on 
the eligibility criteria. The full texts from all potentially eligible papers were ordered and re-reviewed against the 
eligibility criteria. All papers adhering to the criteria on assessment of full texts were included in the review.  In 
case of disagreement at any stage of the selection of studies, a third author acted as adjudicator (CF). 
All key study data was extracted onto a pre-defined data extraction sheet. Three review authors (CF, AB, TS) 
performed this task independently. Data extracted included: study design; patient population characteristics such 
as age, gender, cognitive impairment, co-morbidities to dementia, age at diagnosis, duration from symptom onset 
to diagnosis; primary care clinician involved in diagnosis and screening; perceived positive and negative effects 
of screening procedure in primary care, and perceptions of primary care early diagnosis and screening programmes 
of cognitive impairment delivered in the community and primary care settings. 
Assessment of Study Quality 
The quality of the identified studies was assessed using the CASP critical appraisal tools [11]. Studies were 
classified as high, moderate and low quality using the threshold values of low (0-5 points), moderate (6-8 points) 
and high (9-10 points). The relevant CASP tool was selected to reflect the study design. Any disagreements in 
study identification, data extraction or appraisal were resolved through discussion between the three reviewers 
(FC, AB, TS), or adjudication with a fourth reviewer (CF).  
Data Analysis 
The purpose of this review was to determine reported clinical practice in primary care for early diagnosis and 
screening programmes for dementia, including who should/does undertake this and what may be the positive and 
negative effects of this practice. These later parameters are based on the opinions and attitudes of all stakeholders 
including patients and carers, primary and secondary care clinicians, health care commissioners and academics. 
As the intention of this analysis was to describe practice and both attitudes and opinions, a descriptive analysis 
was undertaken with a narrative review rather than a pooled analysis of results. Frequency of responses and 
attitudes towards early diagnosis or screening and difference between health care clinicians and patient attitudes 
(where appropriate) to these diagnostic pathways were recorded and presented narratively.   
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RESULTS 
 
Search Results 
Figure 1 presents a summary of the search results. In total, from 215 citations, 121 were screened after removal 
of duplicates. From these, 66 citations were excluded since it was clear from both their titles and abstracts that 
they did not meet the eligibility criteria. The full-text of 55 were reviewed, with 22 studies excluded on full-text 
review. Of these four were not based in a primary care/community setting, five were not related to early diagnosis 
of dementia, and 13 did not provide data answering one of more of the a priori research questions. The remaining 
33 studies were identified as meeting the eligibility criteria and were included in the review.  The study designs 
and characteristics of the included papers are presented in Table 2. 
Quality Assessment 
Twenty-six papers presented original research findings and were critically appraised for risk of bias. Seven papers 
were commentary review papers and therefore not assessed using a critical appraisal tool. A summary of the 
quality of the included papers is presented in Table 3. This illustrates that the evidence was of moderate to high 
quality. With the exception of Perry [12], an RCT, the remaining studies used various methods: qualitative 
methods were used to assess the attitudes and perceptions of primary care clinicians to early diagnosis; surveys to 
assess current practices in early diagnosis and implementation studies of early and supported dementia diagnosis 
or screening programmes. Recurrent strengths in the literature included the clear identification of participant 
recruitment processes (97%), clear data collection processes (94%), sufficient follow-up of participants with 
minimal attrition (94%), and assessing outcomes over a sufficient follow-up interval to provide valuable data 
(97%). Recurrent limitations were not controlling or accounting for possible factors, which could have confounded 
outcomes (15%) and not presenting quantitative data (when indicated) with confidence intervals to gain an 
indication of the precision of the finding (18%).  
Clinical practices of primary care early diagnosis or screening for dementia 
There has been little literature exploring what clinical practices are for the early diagnosis or screening for 
dementia in primary care. Four studies explored screening practices in primary care for early diagnosis of dementia 
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[13,14,15,16]. There was considerable heterogeneity in how such screening programmes were delivered. 
Diagnostic practices were based on either opportunistic or formal (sub-populations) until the ‘75 years and over 
check’ in the United Kingdom was introduced [13]. Banerjee et al [17] paper reported an early 
identification/diagnostic intervention specifically designed to provide early assessment and management of people 
with dementia largely delivered in their own homes in South London. Most recently Russell et al [16] reported 
the results of using Read codes to identify, people who may have dementia or be at risk of dementia, then to assess 
these individuals as part of a Quality and Outcomes Framework (QOF) review. 
 
Whilst formal screening was supported in Iliffe et al’s [13] review of UK GP attitudes in a workshop on dementia 
diagnosis, such a potential programme was considered as unfeasible by other respondents due to the reported 
prevalence of dementia and large number of potential patients. The time and resources required were considered 
too great to make a national screening programme feasible [13]. However opportunistic screening was considered 
inappropriate given the time it takes to execute assessments using tools such as Mini-Mental State Examination 
(MMSE) [18] and Abbreviated Mental Test Score (AMTS) [19] which could not be included in a GP consultation 
in addition to the original reason for the GP appointment [13].  
 
In contrast Manthorpe et al [15] presented findings from 24 workshops across 21 UK cities on community 
healthcare professionals’ role in early dementia diagnosis. They reported agreement that opportunistic screening 
was both appropriate and possible suggesting that as part of routine consultations professionals could detect ‘cues’ 
of cognitive impairment such as behaviour change, reduced self-care and agitation.  
 
The exact timing of when to investigate early dementia was explored by Hansen et al [13] in a qualitative study 
of Australian GPs practice in dementia assessment. The two most commonly adopted times were when (1) patients 
or their family members present to the GP complaining of declining memory, reduced emotional control, change 
in social behaviour or (2) where there is a decline in thinking and planning activities. Hansen et al [13] 
acknowledged that diagnosis could be made when the GP observes ‘early pointers’ which include forgetting 
appointments or medications, social withdrawal and decline in self-care. However, it was acknowledged that these 
can be difficult to detect or may be interpreted incorrectly, with GP’s attributing such symptoms to tiredness, old 
age or depression [13]. Boise et al [20] highlighted, in their findings from 18 focus groups of 78 GPs, that family 
members and carers frequently provide the contextual information about the patient’s behaviour that would 
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provide the trigger to further diagnostic investigations. Without this family or carer input the early diagnosis of 
dementia in primary care was considered challenging, with the subtlety of dementia recognition in the early phases 
a considerable barrier to initial recognition which is further intensified by a patient’s denial or refusal to accept 
what is happening.  
 
Holsinger et al [21] presented their findings from the Dementia Screening and Perceived Harms (SAPH) 
questionnaire in two older adult populations in primary care. They reported that 86% of the 345 patients 
approached were happy to be screened, and that it was feasible to incorporate a screening programme into clinical 
practice with minimal disruption. Fowler et al [22] examined 554 community-dwelling individuals aged 65 years 
and older in Indiana for their willingness to be screened for dementia. They found that 90% of participants agreed 
to screening, suggesting its adoption is positively viewed. However, more recently Fowler et al [23] report only 
63% acceptance in a cohort of 400 people when the Perceptions Regarding Investigational Screening for Memory 
in Primary Care (PRISM-PC) questionnaire was used as the screening tool. However no studies have reported 
how this or other potential screening tools are used in non-research driven clinical practice. 
 
Banerjee et al’s [17] Croydon Memory Service Model was assessed through 290 consecutive referrals over a six-
month period. They reported that this multi-disciplinary intervention successful engaged with minority ethnic 
groups, younger adults (17% of referrals to under 65 years old), and successfully decreased behaviour disturbance 
(assessed using the Neuropsychiatric Inventory) and increased quality of life (assessed using the self-rated 
DEMQOL or carer-rated DEMQOL-Proxy) [24] for those who used the service. However this follow-up data was 
based on the responses of 141 participants and therefore may provide biased results from a self-selecting sample. 
Nonetheless the refusal rate for dementia assessment was only five percent, suggesting acceptance as 
demonstrated in other studies such as Holsinger et al [21] and Fowler et al [22,23]. 
 
Rather than developing a new service or screening programme, Russell et al [16] reported using Read codes to 
identify individuals at risk of dementia on primary care patient lists. They recruited 23 general practices from 19 
areas of London with a total practice population of 179,312 with 19,562 patients aged 65 years or older. This 
intervention, which cost each practice an average of 4.7 hours of administration time, increased the number of 
identified people with dementia from 1007 to 1139 people. This represents an increase in identification rates of 
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8.8% (p=0.004) with a purposeful strategy in a population who may not have attended their GP clinic for an 
alternative reason.  
 
Who should provide early diagnosis of dementia in primary care? 
 
Nine studies were identified which specifically explored 'who' should deliver screening programmes for people 
with dementia [12,17,25,26,27,28,29,30,31].  
 
Iracleous et al’s [25] survey of 249 GPs in Canada reported overwhelming agreement that cognitive impairment 
assessment was important in primary care (89% agreed); 92% further agreed that screening should not be left to 
specialist services, with GPs taking a leading role in cognitive screening. 
 
Manthorpe and Iliffe [26] assessed perceived difference in confidence of diagnosis between community mental 
health nurses (CMHN), community nurses and practice nurses. They reported that CMHNs were most confident 
about diagnosing dementia (87%) compared to 46% of community nurses and 42% of nurse practitioners. 
However, when asked about confidence of diagnosing people who presented with mild cognitive impairment, 
only 11% of CMHNs felt confident of their diagnostic skills, although this was greater than community nurses 
(3%) and practice nurses (8%). In their workshops on screening for dementia, Manthorpe et al [13] identified an 
array of professional groups who may appropriately undertake screening for cognitive impairment. These included 
practice nurses, health visitors, community or district nurses, community psychiatric nurses, GPs, other 
(unspecified) nurse, social workers, memory clinic staff and lay person/voluntary organisations. This multi-
disciplinary approach was supported in Banerjee et al’s [17] Croydon Memory Service Model, which was based 
on a team of physicians and nurses training in dementia assessment and care, working as a “core generic team”. 
 
There appeared consensus, within the reviewed European literature, that general practitioners and family 
physicians were confident about their capability to identify cases of people with dementia with 81% of 113 GPs 
in the East of England reporting being confident [27]. However Cahill et al [28] report that GPs in Ireland may be 
afraid to diagnose dementia and initiate treatment, had limited time to undertake a thorough assessment and 
therefore felt that routine GP consultations might not be the optimal place to undertake such an assessment. This 
study of 300 GPs in Ireland also highlighted a lack of GP education on dementia diagnosis in both undergraduate 
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and postgraduate education. They also highlighted that in rural primary care services, difficulties in accessing 
computer tomography and magnetic resonance imaging facilities provided a key obstacle to dementia diagnosis 
[28]. From a worldwide perspective, Turner et al [30] reported that only 50% of their cohort of 127 GPs had 
sufficient basic knowledge to make an early detection of diagnosis and therefore training may be a major challenge 
when considering who should undertake this screening. 
 
Education and training in primary care services for dementia diagnosis has been investigated in two studies. Perry 
[12] reported a cluster randomised controlled trial of usual care versus education through a dementia training 
programme for family physicians and practice nurses in the Netherlands. The intervention consisted of two 
workshops, individual coaching, Internet support and a computerised decision support system. They concluded 
that there was a significant difference in the number of assessments of potential patients (92% versus 32%) and 
diagnoses made in routine primary care compared to practices that did not have access to the dementia training 
programme (49% versus 15%; p<0.001). There was also greater adherence to national dementia management 
guidelines in the dementia training programme clusters (74% versus 42%). Secondly, Pond et al [29] reported the 
reliability of dementia diagnosis following a 15 minute face-to-face training intervention with a GP academic 
fellow with a special interest in geriatric dementia. They reported no significant improvement in the reliability of 
dementia diagnosis during a six month period hence raising questions about the value of this brief intervention. 
This contrast in results may well reflect the differing intensity and levels of training offered. 
 
Martin et al [31] uniquely, explored the issues around dementia screening with patients and the public. In their 
interviews patients largely felt that clinicians should be qualified to undertake the assessment and therefore 
training was critically important. When asked about which professional group should undertake these assessments 
there was limited agreement with participants suggesting that it was the specialist training that was important. 
This could be social services, or health care professional such as a GP or nurse. Some respondents favoured this 
being a GP proposing that the family GP knows the individuals and that this familiarity could be beneficial. They 
suggested that this may make the acceptance of the result easier if there is trust and a strong rapport between the 
patient and GP. In contrast, others argued that this shouldn't be the GP as they have insufficient time to do such 
an important assessment and may not be adequately skilled [31]. 
 
What are the positive and negative effects  of early diagnosis in primary care? 
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Positive Effects 
 
Six positive effects of primary care screening and early diagnosis of dementia  included improved long-term 
outcomes, increased detection, increased ability to plan; better psychological adjustment; avoidance of 
institutionalisation and income generation. 
 
Improved long and shorter-term outcomes: Three papers [17,25,30] provided evidence of improved long-term 
outcomes.  Nationally instigated, improved mechanisms aimed to improve rates of diagnosis and capture all rather 
than some of the patients with cognitive impairment, could increase their long-term outcome if treatment 
interventions develop and progress. However, a survey of 249 GPs in Canada suggested 35% were undecided 
whether dementia screening would improve outcomes for patients in primary care [25]. Banerjee et al [17]’s 
findings of the Croydon Memory Service Model provided favourable findings for the adoption of a multi-
disciplinary team memory service delivered in people’s homes. They reported a significant difference in reduced 
behaviour disturbance and improved quality of life for individuals who were assessed as part of this service, during 
their six month follow-up period [17]. 
 
Increased detection: Three papers indicated that early dementia interventions and screening can increase the levels 
of detection of people with dementia, and are therefore effective [32,33,34]. Iliffe et al [33] reported that in their 
cohort of 139 patients screened in primary care in the London area, 99% of procedures (138/139) were undertaken 
and reported electronically after a ‘pop-up’ was used as a reminder to screen, with significantly more patients 
identified through this screening programme than normal clinical practice (P≤0.01). These findings reflect earlier 
reporting from a study of 659 individuals in New England [34].  
 
Increased planning: Seven papers [13,31,35,36,37,38,39] describe the importance of planning health and social 
care provision before cognitive impairment has a significant impact on an individual’s health, well-being and 
independence. It is proposed that this allows patients and families to be introduced early to agencies, which can 
improve quality of life and reduce risk of crises [37,38]. Early education for the patient and their family could 
avert crisis events when a person with dementia becomes critically unwell, which can be costly and distressing 
for them and for their family and carers [35,39]. 
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Psychological adjustment: One paper explored the possibility that an early diagnosis of dementia might reduce 
psychological distress for individuals and their family or carers [13]. An early diagnosis may provide more time 
for patients and families to come to terms with the diagnosis and psychologically adjust [13]. This could be 
considered a significant advantage, particularly in improving quality of life for the individuals concerned.  
 
Avoidance of institutionalisation: This potential advantage of screening and early diagnosis was discussed in five 
papers [13,17,35,36,40] which describe how it may facilitate planning provision of in-home support to reduce 
institutionalisation, increase independence and wellbeing of patients and support for families and carers [13,35]. 
This may also have a significant benefit on the quality of life for people with dementia and their carers [35]. 
Banerjee and Wittenberg [40] performed a cost-effectiveness analysis using the data from the Croydon Memory 
Service Model [17]. They reported that whilst such a new service would cost approximately £220 million extra 
per year nationally in England, the estimated saving of 10% of care home admissions could be prevented by Year 
10, saving £120 million in social care costs and £125 million in private expenditure (patient and family/carer). 
This was therefore deemed as a potentially cost-effective intervention on the costs associated with 
institutionalisation alone [17].  
 
Income generation: The idea that population screening might be an economical model for private health providers 
was suggested in one paper [36]. Whilst negative effects of early detection and screening may include costs 
associated with such programmes and continuing support for those who are diagnosed with cognitive impairment, 
for private health services this may create a new market. Therefore primary care screening provided by social 
enterprises or private health providers, given the high prevalence of dementia, could be an economically viable 
market, which has previously been under-represented [36]. 
 
Negative Effects 
 
Eight negative effects to adoption of primary care screening and early diagnosis for dementia were identified from 
the evidence. These included over-diagnosis with poor prognostic value, insufficient evidence, a dearth of 
treatment options, social consequences, psychological consequences, costs associated; and limited service 
capacity to respond. 
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Misdiagnosis: Seven papers [13,30,35,36,37,41,42] discuss how early dementia with mild cognitive impairment 
could  be diagnosed, which then however doesn’t become established as a true dementia. This could lead to undue 
anxiety and ‘scare mongering’ about the patient's future and increased anxiety for the patient [35] and their family, 
as well as unnecessary service provision and lifestyle changes pre-dementia. Early diagnostic screening by 
imaging will detect only catastrophic changes especially for those aged 80 years and older and therefore risk 
cannot really be fully evaluated, particularly for those with cerebral co-morbidities [36]. There is currently 
insufficient evidence to support a specific screening measure or diagnostic test with acceptable accuracy for early 
dementia in primary care [41]. Beach et al [42] reported that the diagnosis of dementia sensitivity values ranged 
from 71% to 87%, but specificity values ranged from 44% to 71%; this provides further questions regarding a 
high misdiagnosis rate for early diagnosis of dementia.  
 
Prognostic value: The prognostic value of dementia screening has been questioned in three papers [31,36,37], 
pointing out that whilst diagnosis is valuable, prognosis is then needed by patients and families to become 
meaningful. Thus it could be argued that diagnosis is not a valuable addition to healthcare provision without 
further evidence about how this can usefully inform people’s futures. 
 
Insufficient evidence-base: There is a paucity of research from intervention trials to support the provision of early 
diagnosis of dementia [13,31,36,37,41,42,43,44] and no strong evidence for accurate diagnoses of dementia in 
early phases [35,36,41,45]. Patients and the public also expressed concerns, stating that they thought it was 
critically important to establish the accuracy of the test before it should be used in clinical practice [31]. There is 
also no strong evidence to support the benefit of early diagnosis [42], a view supported by the UK national 
screening committee who highlighted this is as problematic, particularly given the absence of diagnostic screening 
criteria [45]. There is, therefore, insufficient evidence to support the adoption of early detection over later 
diagnosis [45]. 
 
Ineffective treatment: The lack of treatment options is a particular disadvantage of early diagnosis of dementia 
[31,35,36,37, 41,6]. Apart from symptomatic treatments there are currently no effective treatments for this 
population and therefore early diagnosis may raise fears, without any effective treatment options [35,36]. This 
means such a diagnosis could therefore be perceived as a potential 'death sentence', with potential long-term 
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negative psychological implications for individuals [31]. Furthermore, with the recognised possibility of over 
diagnosis, the NHS and social care sectors may not be able to afford to provide additional support to all 
individuals, given such potential high numbers of positively screened people.   
 
Social consequences: The implications for wider society and the relationship between society and the patient were 
considered important negative effects in four papers [13,31,35,46,47]. It is possible that the results of the screening 
could affect employment status and options or health insurance and life insurance premiums, which may have 
social consequences for individuals and their families [35]. There could be stigma related to a diagnosis of 
dementia, which could then create social isolation and a loss of independence [31,35,46,47]. This may also affect 
or alter the social networks the person has, with potentially further negative social and psychological 
consequences.  
 
Psychological consequences: Three papers explored potential psychological consequences of an early diagnosis 
of dementia [13,35,46,47] suggesting those affected could develop anxiety and depressive symptoms following 
the diagnosis with concerns regarding their future. The social consequences (stigma) of such a diagnosis may also 
cause social isolation and even greater anxiety and depression, which might develop further or spiral 
[13,34,46,47].   
 
Financial Implications: The economic costs associated with providing dementia, screening programmes at a 
population-level, and early diagnosis of dementia for the public, were presented in six papers [13,31,35,36,40,41]. 
Given the high prevalence of cognitive impairment and dementia in the population, some authors have questioned 
how cost-effective such assessments would be in current health services worldwide [31]. Given the paucity of 
cost-effectiveness literature, there is a perception that this might not be value for money in the National Health 
Service [35]. However, Banerjee and Wittenberg’s [40] analysis refuted this as highlighted above. Furthermore, 
if there is an increase in the number of people diagnosed, support and care will be required for these people, 
potentially at an earlier time than those diagnosed later, which would have further cost-implications in relation to 
the overall management for the population, and this may or may not be cost-effective [13,36]. There is therefore 
currently insufficient evidence that a screening programme or early diagnosis of dementia can be cost-effective 
in primary care [40]. 
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Service capacity: Concerns regarding the practicalities of providing an early diagnosis in dementia were presented 
by Jacinto et al [38] and Iliffe et al [13] and currently primary care services are under pressure due to the number 
of patients seen within routine practice. Given the growing ageing population, the literature suggested that 
screening for cognitive impairment in primary care could only be delivered if economically incentivised. 
Additionally, some authors have questioned whether GPs and primary care nurses have the skills to be able to 
diagnose cognitive impairment in early screening. This would need to be addressed, with associated costs in 
training and education across the UK, to effectively provide this service. In Brazil for example, only 50% of GPs 
were reported to have the knowledge to apply early dementia screening tests. This could therefore be a major 
limitation, leading to worldwide problems in implementation [38].  However Iliffe et al [13] suggest that an early 
diagnosis screening programme or encouragement to diagnose people early in primary care may provide the 
impetus to improve knowledge about dementia diagnosis, so providing an opportunity to increase the relevant 
skills. 
 
 
DISCUSSION 
 
The findings of this review indicate that there is limited empirical research regarding the feasibility and usefulness 
of a screening programme and early diagnosis assessments within primary care. A significant proportion of the 
current literature on early screening programmes is based on healthcare professionals and patients views which 
although providing valid and interesting perceptions do not address the effect on clinical outcomes. Furthermore, 
given the poor evidence-base underpinning diagnostic accuracy, issues remain whether people could be over- or 
under-diagnosed. Until there is further evidence for the clinical and cost-effectiveness of early diagnosis and 
screening and until appropriate training and support for health care professionals is developed to implement such 
programmes, early diagnosis through screening is not an evidence-based intervention for current community care 
systems.  
A major theoretical limitation to implementing an early diagnosis and screening programme for diagnosis in 
primary care concerns which healthcare professionals should take responsibility for this. Given the large number 
of patients who would need to be assessed in an ageing population, all healthcare professionals should take 
responsibility, screening and assessing opportunistically. Given that 80% of the population receive a primary care 
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appointment each year [48], such a strategy would appear realistic and achievable, if the assessment procedure 
could be undertaken within the constraints of a conventional primary care consultation. However, previous authors 
have suggested that those with moderate cognitive impairment consult their primary care physicians less 
frequently than those with no or mild cognitive impairment [49]. Accordingly such opportunistic strategies could 
fail to include a large number of individuals in particular need. Furthermore, this may be inappropriate given that 
early indications of cognitive decline can be more subtle changes in behaviour, memory and character, which are 
difficult to detect during a short consultation Martin et al [8]. Additionally there is often a reliance on reports from 
other family members, who may be less likely to mention this unless they had sought a consultation regarding 
dementia screening [31].   
The need for training and educational support has also been highlighted as a recurrent argument against 
opportunistic diagnosis approaches, with authors such as Perry [12] and Manthorpe and Iliffe [26] suggesting that 
healthcare professionals in primary care need specific training in assessment approaches. Such a requirement 
raises issues of training costs and support, particularly for a nationwide diagnostic programme. Whilst a focus on 
specialist community nurses and psychiatric services may be a more realistic approach given their specialist skills, 
ensuring there is universal coverage and referral pathways to such services for all may be a logistical and financial 
challenge which may not be attainable in many health services. 
The literature in this review highlighted the psychological and social implications following a diagnosis of 
dementia. There is suggestion that this may be beneficial to facilitate the early planning of care support and 
avoidance of ‘crises’ when the cognitive impairment starts to have a greater impact on inadequate family or carer 
support. Whilst in contrast the psychosocial implications, such as fear around loss of insurance, increased private 
health care premiums, loss of current employment and future employment opportunities, as well as relationship 
and family tensions which may culminate in social isolation and stigmatisation within wider society, have been 
widely reported within the literature [50,51,52]. Improved awareness of the consequence of mild cognitive 
impairment would appear an important precursor to prepare individuals before being screened with better 
information for family members, friends, employers and the government and public agencies is also required. 
Therefore, whilst implementation of early diagnostic and screening programmes may appear to only be important 
to primary care providers, in reality, this has far greater consequences for both wider sections of the public sector 
and society in general. 
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Given these challenges it is not surprising that at present screening programmes and early diagnosis are largely 
limited to research programmes and investigational rather than routine practice. The evidence underpinning the 
adoption of screening programmes in small, regional-population based cohorts, which are easily controlled, 
provides an indication of the potential for screening implementation [21,22,23]. However, it is difficult to 
generalise the findings from these to a national-level given the variations in population characteristics and 
difficulties in managing macro and meso-level system change. Such studies should only be considered once the 
evidence concerning the diagnostic test accuracy of screening tools, and the cost-effectiveness of such 
programmes at a national level have been studied and modelled.   
 
CONCLUSIONS 
 
Currently there is insufficient evidence, both in quality and quantity, to support the adoption of early diagnosis or 
screening programmes for dementia in primary care. When evidence develops to support diagnostic capabilities 
and therapeutic options for those diagnosed with early-onset dementia, the implementation of community-based 
screening programmes and early diagnosis should be re-evaluated. With  additional sociological investigation to 
explore the psychosocial implications and meaning of dementia for individuals, family, friends, employers and 
for wider society will need to be considered further to better address current fears and stigmas related to diagnosis.   
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Figure 1: PRISMA Flow-Chart 
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Table 1: MEDLINE search strategy 
 
 
 
 
 
1. exp Dementia/ 
2. Dementia, Amnestic, Cognitive Disorders/ 
3. dement*.mp. 
4. vascular dementia.mp. 
5. alzheimer*.mp. 
6. (lewy* adj2 bod*).mp. 
7. (chronic adj2 cerebrovascular).mp. 
8. (cerebr* adj2 deteriorat*).mp. 
9. (cerebral* adj2 insufficient*).mp. 
10. ("organic brain disease" or "organic brain syndrome").mp. 
11. OR/1-10 
12. exp Primary Health Care/ 
13. exp Community Health Services/ 
14. community physician.mp. 
15. family doctor.mp. 
16. general practi*.mp. 
17. OR/12-16 
18. diagnosis.mp. 
19. screening.mp. 
20. OR/18,19 
21. AND/11,17,20 
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Table 2: Characteristics of Included Studies  
 
Study Name Origin  Study Design Cohort Profession Screening tool Appraisal 
Quality 
Ashford et al [41] 
 
USA Commentary Not assessed Not assessed Not applicable 
Banerjee et al [17] UK Mixed-methods analysis of 
implementation of a memory service 
Multidisciplinary (physicians 
and nursing) 
Not assessed Low 
Banerjee and 
Wittenberg [40] 
UK Health economic analysis of a 
memory service 
Multidisciplinary (physicians 
and nursing) 
Not assessed Moderate 
Boise et al [32] USA Quantitative analysis of 
implementation of Screening 
Programme 
6 rural GP practices in Oregon 
USA including 18 clinicians and 
26 medical assistants 
Rural Older Adult 
Memory Evaluation 
Moderate 
Boise et al [20] USA Qualitative investigation with focus 
groups 
78 primary care physicians Not assessed High 
Bond et al [43] France, Germany, 
Italy, Spain and the 
United Kingdom 
Survey of carers, commissioners, GP 
and general public to dementia 
screening 
1000 public responses, 250 
caregivers, 50 commissions. 
Not assessed Moderate 
Borson et al [35] 
 
USA Commentary Not assessed Not assessed Not applicable 
Borson et al [53] USA Quantitative analysis of 
implementation of Screening 
Programme 
524 community-dwelling 
individuals assessed by 26 
medical assistants  
Mini-Cog High 
Boustani et al [46] USA Survey of attitudes towards dementia 
screening 
81 people with dementia 
caregiving experience and 125 
people without dementia 
caregiving experience 
Not assessed Moderate 
Cahill et al [28] Ireland Survey of GPs and 2 focus groups Survey: 300 GPs; Focus Group: 
7 GPs in 1 urban and 1 rural 
practice 
Not assessed High 
Chinthapalli [39] 
 
UK Commentary Not assessed Not assessed Not applicable 
Fowler et al [22] USA Quantitative analysis of attitudes 
towards screening programme 
554 patients in primary care Perceptions Regarding 
Investigational Screening 
for Memory in Primary 
Care (PRISM-PC) 
High 
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Fowler et al [23] USA Quantitative analysis of attitudes 
towards screening programme 
400 patients in primary care Perceptions Regarding 
Investigational Screening 
for Memory in Primary 
Care (PRISM-PC) 
High 
Fox et al [36] UK/USA 
 
Commentary Not assessed Not assessed Not applicable 
Fox et al [37] UK/USA 
 
Commentary Not assessed Not assessed Not applicable 
Fox et al [27] UK 
 
Survey of GPs 113 GPs in East of England Not assessed Moderate 
Hansen et al [14] Australia Qualitative investigation with focus 
groups. 
24 GPs in urban and rural 
practices 
Not assessed High 
Holsinger et al [21] USA Quantitative analysis of 
implementation of Screening 
Programme 
345 patients in primary care Dementia Screening and 
Perceived Hames 
(SAPH) questionnaire 
High 
Iliffe et al [13] UK NGT consensus during workshop 247 GPs; 146 CN; 36 PN; 79 
CMHN 
Not assessed High 
Iliffe et al [33] UK Quantitative analysis of 
implementation of Screening 
Programme 
2 GP practices in London UK MMSE and clinical 
history/examination 
High 
Iracleous et al [25] Canada Survey on GP perceptions of 
screening for dementia.  
249 GP responses Not assessed Moderate 
Jacinto et al [38] 
 
Brazil Letter Not assessed. Not assessed Not applicable 
Justiss et al [47] USA Survey of attitudes towards dementia 
screening 
245 older adults in USA n=125) 
and UK (n=120) 
Not assessed Moderate 
Lawrence et al [34] USA Quantitative analysis of 
implementation of Screening 
Programme 
659 community-dwelling 
individuals 
7-Minute Screen High 
Manthorpe et al 
[15] 
UK Survey data from workshop 24 one-day workshops across 21 
UK cities with primary care 
staff 
Not assessed High 
Manthorpe et al 
[26] 
UK Survey data from workshop 1536 CN; 36 PN; 79 CMHN Not assessed High 
Martin et al [31] UK Qualitative analysis of workshop 36 people; 8 Alzheimer Society 
Research Network volunteers 
Not assessed High 
Martin et al [8] UK Systematic review of patients/carer 
attitudes towards screening 
29 eligible papers Not assessed Not applicable 
29 
 
Perry [12] Netherlands Randomised Controlled Trial 105 family physicians and 
primary care nurses 
Not assessed Moderate 
Pond et al [29] Australia Educational support to implement 
diagnosis in a pre-test post-test study 
13 GPs in Australian urban 
practices. 200 patients 
The Canberra Interview 
for the Elderly (CIE) and 
MMSE. 
Moderate 
Russell et al [16] UK Quantitative analysis of a Read Code 
detection system 
23 GP practices in 19 regions of 
London 
Not assessed Moderate 
Turner et al [30] UK Survey of GPs 127 GPs from 20 Scottish and 
16 London GP practices 
Not assessed Moderate 
US Preventive 
Services Task [44] 
USA Recommendations/Guidelines Not assessed Not assessed Not applicable 
CMHN – community mental health nurses; CN – community nurses; GP – general practitioners; MMSE – mini-mental state examination; NGT – Nominal Group Technique; 
PN – practice nurses 
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Table 3: Summary of critical appraisal results 
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Did the study address a clearly focused issue?             
Was the cohort recruited in an acceptable way?     X        
Was the exposure accurately measured to minimize bias? X X   X        
Was the outcome accurately measure to minimize bias?             
Have the authors identified all important confounding factors? X X X U X U X X   X  
Was the follow up of the subjects complete enough? X            
Was the follow up of subjects long enough? X            
Where confidence intervals presented? X X X N/A X X X N/A   X N/A 
Were the results generalisable to the general population?             
Do the results of this study fit with other available evidence?             
 - satisfied; X – not satisfied; N/A – not applicable; U – unclear 
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